Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?

详细信息    查看全文

• 作者：Eleanor M. Pullenayegum ; Kuhan Perampaladas…
• 关键词：Health utility ; EQ ; 5D ; Scoring algorithm ; Heterogeneity ; I100 ; C190
• 刊名：The European Journal of Health Economics
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：16
• 期：8
• 页码：847-855
• 全文大小：454 KB
• 参考文献：1.National Institute for Health and Care Excellence: Guide to the methods of technology appraisal. National Institute for Health and Care Excellence, London, UK. http://鈥媝ublications.鈥媙ice.鈥媜rg.鈥媢k/鈥媝mg9 (2013)
  2.Canadian Agency for Drugs and Technology in Health: Guidelines for economic evaluation of health technologies, 3rd edn. Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada (2006)
  3.EuroQol鈥揳 new facility for the measurement of health-related quality of life.: The EuroQol group. Health Policy. 16, 199鈥?08 (1990)
  4.Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35, 1095鈥?108 (1997)CrossRef PubMed
  5.Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med. Decis. Making 21, 7鈥?6 (2001)CrossRef PubMed
  6.Johnson, J.A., Luo, N., Shaw, J.W., Kind, P., Coons, S.J.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221鈥?28 (2005)CrossRef PubMed
  7.Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value set: the case of Japan. Health Econ. 11, 341鈥?53 (2002)CrossRef PubMed
  8.Shaw, J.W., Johnson, J.A., Chen, S., Levin, J.R., Coons, S.J.: Racial/ethnic differences in preferences for the EQ-5D health states: results from the USA valuation study. J. Clin. Epidemiol. 60, 479鈥?90 (2007)CrossRef PubMed
  9.Shaw, J.W., Johnson, J.A., Coons, S.J.: USA valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 43, 203鈥?20 (2005)CrossRef PubMed
  10.Jo, M.W., Yun, S.C., Lee, S.I.: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea. Value Health 11, 1186鈥?189 (2008)CrossRef PubMed
  11.Zarate, V., Kind, P., Valenzuela, P., Vignau, A., Olivares-Tirado, P., Munoz, A.: Social valuation of EQ-5D health states: the Chilean case. Value Health 14, 1135鈥?141 (2011)CrossRef PubMed
  12.Macaran S, Kind P.: Valuing EQ-5D health states using a modified MVH protocol. Prelim. Results 16, 205鈥?9 (1999)
  13.Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121鈥?132 (2006)CrossRef PubMed
  14.Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186鈥?94 (2011)CrossRef PubMed
  15.Viney, R., Norman, R., King, M.T., et al.: Time trade-off derived EQ-5D weights for Australia. Value Health 14, 928鈥?36 (2011)CrossRef PubMed
  16.Wittrup-Jensen, K.U., Lauridsen, J., Gudex, C., Pedersen, K.M.: Generation of a Danish TTO value set for EQ-5D health states. Scand. J. Public Health 37, 459鈥?66 (2009)CrossRef PubMed
  17.Bansback, N., Tsuchiya, A., Brazier, J., Anis, A.: Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One 7, e31115 (2012)PubMed Central CrossRef PubMed
  18.Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., Busschbach, J.J.: Valuation of EQ-5D health states in poland: first TTO-based social value set in central and eastern Europe. Value Health 13, 289鈥?97 (2010)CrossRef PubMed
  19.Norman, R., Cronin, P., Viney, R., King, M., Street, D., Ratcliffe, J.: International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 12, 1194鈥?200 (2009)CrossRef PubMed
  20.Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum EM.: Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med. Decis. Making 22 Mar 2013 (epub ahead of print)
  21.Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12, 587鈥?96 (2009)CrossRef PubMed
  22.Chevalier J, de Pouvourville G.: Valuing EQ-5D using time trade-off in France. Eur. J. Health. Econ. (2011)
  23.Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M.: Validating the EQ-5D with time trade-off for the German population. Eur. J. Health. Econ. 6, 124鈥?30 (2005)CrossRef PubMed
  24.Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul. Health Metr. 1, 11 (2003)PubMed Central CrossRef PubMed
  25.Kind, P.: Valuing health benefits using the EQ-5D: the West Lothian question. In: Stavem, K. (ed.) 22nd Plenary meeting of the EuroQol Group, Oslo, Norway, pp. 55鈥?7 (2005)
  26.Shaw, J.W., Pickard, A.S., Yu, S., et al.: A median model for predicting United States population-based EQ-5D health state preferences. Value Health 13, 278鈥?88 (2010)CrossRef PubMed
  27.Zarate, V., Kind, P., Chuang, L.H.: Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health 11, 1170鈥?177 (2008)CrossRef PubMed
  28.Chang, T.J., Tarn, Y.H., Hsieh, C.L., Liou, W.S., Shaw, J.W., Chiou, X.G.: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J. Formos. Med. Assoc. 106, 1023鈥?031 (2007)CrossRef PubMed
  
• 作者单位：Eleanor M. Pullenayegum (1)
  Kuhan Perampaladas (2)
  Kathryn Gaebel (2)
  Brett Doble (3)
  Feng Xie (2)
  
  1. Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, ON, Canada
  2. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
  3. Faculty of Business and Economics, Centre for Health Economics, Monash University, Clayton, VIC, Australia
  
• 刊物类别：Business and Economics
• 刊物主题：Economics
  Economic Policy
  Public Health
  Public Finance and Economics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1618-7601

文摘

Background EQ-5D-3L scoring algorithms vary amongst countries, not only in the values of regression coefficients but also in the independent variables included in the regression model (hereafter referred to as model specification). It is unclear how much of this variation is due to differences in health state selection, the relative frequencies with which health states were valued, and model diagnostics, rather than to genuine differences in population preferences.